Form 4 for CPAY Corpay
Accepted 2024-11-14 00:00:00 ET · period of report 2024-10-23 · accession 0000950170-24-127180 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-14 | 2024-11-12+ | CPAY | Clarke Ronald | CEO, COB of BOD, Dir | M - OptEx | $219.23 | +845.0K | 2.28M | +59% | +$185.25M |
| DM | 2024-11-14 | 2024-11-12+ | CPAY | Clarke Ronald | CEO, COB of BOD, Dir | F - Tax | $374.22 | -651.5K | 2.23M | -23% | -$243.82M |
| D | 2024-11-14 | 2024-10-23 | CPAY | Clarke Ronald | CEO, COB of BOD, Dir | D - Sale to Iss | $261.27 | -300.0K | 550.0K | -35% | -$78.38M |
| DM | 2024-11-14 | 2024-11-12+ | CPAY | Clarke Ronald | CEO, COB of BOD, Dir | M - OptEx | $219.23 | -845.0K | 0 | -100% | -$185.25M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-12 | M | A | 220,000 | $149.68 | 2,258,632 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-12 | F | D | 147,020 | $374.48 | 2,111,612 | D | — | — | (F1) Payment of tax liability and exercise price by withholding securities incident to the exercise of a security issued in accordance with Rule 16b-3 |
| 3 | Common | Common Stock | 2024-11-12 | M | A | 550,000 | $261.27 | 2,661,612 | D | — | — | (F2) In 2021, the Reporting Person was granted performance stock options to purchase 850,000 shares of Issuer common stock with an exercise price of $261.27. The performance options would vest only if Issuer achieved specific stock price hurdles for ten consecutive trading days not later than December 31, 2024. The stock price hurdle for 550,000 shares subject to the award was $350, and the stock price hurdle for the remainder of the award was $400. On October 23, 2024, the Issuer agreed to cancel 300,000 stock options under the second tranche and modify the criterion for 550,000 shares under the first tranche of the performance option award to require that the Issuer achieve a closing stock price at or above $350 for at least 3 trading days by December 31, 2024. This criterion for 550,000 performance shares was achieved as of 10/23/2024. |
| 4 | Common | Common Stock | 2024-11-12 | F | D | 458,118 | $374.48 | 2,203,494 | D | — | — | (F1) Payment of tax liability and exercise price by withholding securities incident to the exercise of a security issued in accordance with Rule 16b-3 |
| 5 | Common | Common Stock | 2024-11-13 | F | D | 46,398 | $370.77 | 2,232,096 | D | — | — | (F1) Payment of tax liability and exercise price by withholding securities incident to the exercise of a security issued in accordance with Rule 16b-3 |
| 6 | Common | Common Stock | 2024-11-13 | M | A | 75,000 | $114.90 | 2,278,494 | D | — | — | |
| 7 | Derivative | Stock Options Holding | 2024-10-23 | D | D | 300,000 | $261.27 | 550,000 | D | $261.27 · — to 2024-12-31 | 850,000 Common Stock | (F2) In 2021, the Reporting Person was granted performance stock options to purchase 850,000 shares of Issuer common stock with an exercise price of $261.27. The performance options would vest only if Issuer achieved specific stock price hurdles for ten consecutive trading days not later than December 31, 2024. The stock price hurdle for 550,000 shares subject to the award was $350, and the stock price hurdle for the remainder of the award was $400. On October 23, 2024, the Issuer agreed to cancel 300,000 stock options under the second tranche and modify the criterion for 550,000 shares under the first tranche of the performance option award to require that the Issuer achieve a closing stock price at or above $350 for at least 3 trading days by December 31, 2024. This criterion for 550,000 performance shares was achieved as of 10/23/2024. |
| 8 | Derivative | Stock Options Holding | 2024-11-12 | M | D | 550,000 | $261.27 | 0 | D | $261.27 · — to 2024-12-31 | 850,000 Common Stock | (F2) In 2021, the Reporting Person was granted performance stock options to purchase 850,000 shares of Issuer common stock with an exercise price of $261.27. The performance options would vest only if Issuer achieved specific stock price hurdles for ten consecutive trading days not later than December 31, 2024. The stock price hurdle for 550,000 shares subject to the award was $350, and the stock price hurdle for the remainder of the award was $400. On October 23, 2024, the Issuer agreed to cancel 300,000 stock options under the second tranche and modify the criterion for 550,000 shares under the first tranche of the performance option award to require that the Issuer achieve a closing stock price at or above $350 for at least 3 trading days by December 31, 2024. This criterion for 550,000 performance shares was achieved as of 10/23/2024. |
| 9 | Derivative | Stock Options Holding | 2024-11-13 | M | D | 75,000 | $114.90 | 250,000 | D | $114.90 · 2017-01-20 to 2026-01-20 | 425,000 Common Stock | |
| 10 | Derivative | Stock Options Holding | 2024-11-12 | M | D | 220,000 | $149.68 | 0 | D | $149.68 · 2015-12-04 to 2024-12-04 | 850,000 Common Stock |